ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,177Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 288

$544K Total Retail Price of All Prescriptions

Rank: 61 out of 288

384 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,845 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 664 655 1 1
LISINOPRIL 647 617 2 4
ATENOLOL 526 506 3 10
OMEPRAZOLE 442 426 4 3
WARFARIN SODIUM 386 385 5 9
LEVOTHYROXINE SODIUM 361 355 6 2
ATORVASTATIN CALCIUM 347 339 7 14
HYDROCHLOROTHIAZIDE 342 322 8 13
METOPROLOL TARTRATE 310 310 9 8
FUROSEMIDE 293 292 10 5
TRAMADOL HCL 260 250 11 19
CITALOPRAM HBR 220 203 12 18
SPIRONOLACTONE 209 209 13 36
AMLODIPINE BESYLATE 195 192 14 6
METOPROLOL SUCCINATE 178 174 15 15
LOSARTAN POTASSIUM 164 164 16 16
GABAPENTIN 141 139 17 17
CRESTOR 130 124 18 26
ALLOPURINOL 123 121 19 23
ISOSORBIDE MONONITRATE ER 119 119 20 35
MIRTAZAPINE 115 114 21 60
TAMSULOSIN HCL 109 108 22 24
SPIRIVA 105 95 23 48
RANITIDINE HCL 103 101 24 33
METFORMIN HCL ER 99 99 25 76
DONEPEZIL HCL 92 92 26 29
GLIMEPIRIDE 92 92 26 32
RAMIPRIL 91 89 28 101
TRAZODONE HCL 88 87 29 37
NAMENDA 88 88 29 39
METFORMIN HCL 86 80 31 12
BENAZEPRIL HCL 85 83 32 52
ENALAPRIL MALEATE 83 78 33 40
GLIPIZIDE ER 83 80 33 93
POTASSIUM CHLORIDE 82 82 35 11
LOVASTATIN 80 80 36 46
SPIRONOLACTONE-HCTZ 73 71 37 186
PAROXETINE HCL 72 68 38 54
CARVEDILOL 69 68 39 27
PREDNISONE 66 63 40 30
CLOPIDOGREL 66 66 40 47
CLONIDINE HCL 64 64 42 70
ZETIA 60 54 43 58
JANUVIA 60 60 43 88
PLAVIX 58 58 45 71
NEXIUM 57 55 46 43
DIGOXIN 54 54 47 51
TRIAMTERENE-HCTZ 53 53 48 28
ALENDRONATE SODIUM 51 51 49 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.